跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 40 条关于
“Maven”
全部
40
临床试验
24
药物
3
机构
1
资讯
12
去年
Magnitude Biosciences Secures £700K to Advance High-Throughput Drug Discovery Platform
去年
Laverock Therapeutics Raises £20M in Expanded Seed Funding, Reports Positive Data for Cancer Cell Therapy Programs
10个月前
Arena BioWorks Shuts Down After Less Than Two Years, Citing Policy Uncertainty and Funding Challenges
10个月前
FamilyWell Health Secures $8M Series A to Expand Integrated Women's Mental Health Platform
去年
MAVENCLAD Shows Sustained Long-Term Benefits in Multiple Sclerosis with Four-Year Data at ECTRIMS 2025
去年
Bionxt Solutions to Evaluate Sublingual Cladribine Formulation for Multiple Sclerosis in Clinical Trial
去年
Rituximab Outperforms Cladribine in Real-World Multiple Sclerosis Study
去年
Merck KGaA Appoints David Weinreich as Global Head of R&D to Revitalize Healthcare Pipeline
去年
Cladribine Plus Venetoclax Shows High Response in AML and High-Risk MDS
去年
New Haven Biopharma Firm Veradermics Raises $75M in Series B Financing Round
第 1 页,共 2 页
上一页
下一页